Logan's Inspiring Journey: Breakthrough Pediatric Cancer Treatment


Read Previous Read Next

Related News

Patient of the Month: Carmella

February 28, 2025 – After Carmella developed bruising and red blood dots on her skin, she was rushed to the emergency room at her local hospital in Palm Beach. Initial tests showed a low platelet count, prompting further testing. At Nicklaus Children’s Helen & Jacob Shaham Cancer & Blood Disorders Institute, Carmella was diagnosed with Severe Aplastic Anemia (AA) and required a bone marrow transplant – her little brother Angelo was a perfect match and became her donor.

Child Gets Second Chance at Life Thanks to Lifesaving Cancer Treatment

November 05, 2024 – Joffre Emmanuel, born with Down syndrome and later diagnosed with acute lymphocytic leukemia, has defied the odds since birth. After unsuccessful treatment in Ecuador, he received lifesaving immunotherapy and CAR T-cell therapy at Nicklaus Children's Hospital, leading to significant improvements and is back to enjoying his childhood.

Helen & Jacob Shaham Cancer & Blood Disorders Institute at Nicklaus Children's Reognized for Excellence in Cancer Registration

August 28, 2025 – The Florida Department of Health and the Florida Cancer Data System (FCDS) has awarded the Helen & Jacob Shaham Cancer & Blood Disorders Institute at Nicklaus Children's the 2024 Jean Byers Memorial Award for Excellence in Cancer Registration. The FCDS recognizes facilities that have met or exceeded the national quality standards for timeliness and completeness in cancer reporting.

The History of Clinical Trials

May 18, 2025 – Researchers around the world celebrate Clinical Trials Day on May 20 in recognition of the incredible advances in medicine made possible by clinical trials. This observance is timed to reflect the launch of the earliest recognized clinical trial by researcher, James Lind. Published in 1753, Lind's work compared several test groups to a control group, to demonstrate the effectiveness of citrus fruit as a treatment for scurvy.